MENU

ESPR Esperion Therapeutics Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products

ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ESPR is expected to report earnings to fall 148.53% to -16 cents per share on July 30

Esperion Therapeutics ESPR Stock Earnings Reports
Q2'24
Est.
$-0.17
Q1'24
Beat
by $0.29
Q4'23
Missed
by $0.03
Q3'23
Beat
by $0.06
Q2'23
Beat
by $0.15
The last earnings report on May 07 showed earnings per share of 34 cents, beating the estimate of 5 cents. With 1.98M shares outstanding, the current market capitalization sits at 495.94M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TESRX25.870.10
+0.39%
Franklin Mutual Shares R
RESGX16.830.05
+0.30%
Glenmede Responsible ESG US Equity
REUYX47.26N/A
N/A
Russell Inv Sustainable Equity Y
ASRAX8.13-0.06
-0.73%
Invesco Global Real Estate Income A
TSONX13.51-0.11
-0.81%
Nuveen International Res Eq R6

ESPR and Stocks

Correlation & Price change

A.I.dvisor tells us that ESPR and RMTI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESPR and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESPR
1D Price
Change %
ESPR100%
+3.63%
RMTI - ESPR
30%
Poorly correlated
-2.90%
CTLT - ESPR
29%
Poorly correlated
+0.09%
PTPI - ESPR
29%
Poorly correlated
+3.60%
AVDL - ESPR
28%
Poorly correlated
-0.06%
SCYX - ESPR
26%
Poorly correlated
+2.97%
More